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ABSTRACT
Deciphering the functions of long non-coding RNAs
(lncRNAs) is facilitated by visualization of their sub-
cellular localization using in situ hybridization (ISH)
techniques. We evaluated four different ISH meth-
ods for detection of MALAT1 and CYTOR in cultured
cells: a multiple probe detection approach with or
without enzymatic signal amplification, a branched-
DNA (bDNA) probe and an LNA-modified probe with
enzymatic signal amplification. All four methods ade-
quately stained MALAT1 in the nucleus in all of three
cell lines investigated, HeLa, NHDF and T47D, and
three of the methods detected the less expressed
CYTOR. The sensitivity of the four ISH methods was
evaluated by image analysis. In all three cell lines,
the two methods involving enzymatic amplification
gave the most intense MALAT1 signal, but the signal-
to-background ratios were not different. CYTOR was
best detected using the bDNA method. All four ISH
methods showed significantly reduced MALAT1 sig-
nal in knock-out cells, and siRNA-induced knock-
down of CYTOR resulted in significantly reduced CY-
TOR ISH signal, indicating good specificity of the
probe designs and detection systems. Our data sug-
gest that the ISH methods allow detection of both
abundant and less abundantly expressed lncRNAs,
although the latter required the use of the most spe-
cific and sensitive probe detection system.
INTRODUCTION
In the last decades, non-coding RNAs (ncRNAs) includ-
ing small ncRNAs likemicroRNA (miRNA), long ncRNAs
(lncRNA) (1), and more recently circular RNAs (circRNA)
(2) have attracted much attention and added yet a layer of
complexity to the regulatorymachinery involved in gene ex-
pression. The number of lncRNAs (3) is much higher than
both the number of protein coding mRNAs and miRNAs
(4–8). The expression of lncRNA is tightly regulated by
key developmental, metabolic and/or external stimuli, sug-
gesting important functional roles (1,9). However, despite
their poor conservation among species compared to mR-
NAs (10–12) and their disputed coding potential (13,14),
roles of lncRNAs in biological and pathological processes
are continuously being identified, revealing their involve-
ment in transcription, signaling and intracellular trafficking
(15–18).
Information regarding the expression dynamics of lncR-
NAs and their subcellular localization are important to help
identifying their biological functions. The expression of
lncRNAs is often tissue-specific and even cell-type specific
(19–21), and therefore the localization of lncRNAs within a
complex tissue can provide important insight on their role in
physiological and pathological situations. On average, lncR-
NAs are shorter and contain more repeats than mRNA
molecules (21,22), and lncRNAs are generally expressed at
lower levels than mRNAs (23), making the lncRNAs chal-
lenging to detect by in situ hybridization (ISH) methods.
In recent years, major advances in probe technologies
and detection methods have been made to improve ISH
methods for RNA visualization. These technologies include
fluorophore-labeled multiple oligo probe sets (24,25), LNA
probes (26) and branched-DNA (bDNA) probes (27–29).
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A multiple probe set contain up to 48 antisense
fluorophore-labeled DNA oligonucleotides (oligos in the
following) that are designed and selected for unique se-
quences in the target RNA molecule and individually la-
beled with fluorophores (24,25). The oligos in a multiple
DNA probe set hybridize along the entire RNA molecule,
which provides sufficient label density to allow visualization
of the RNA molecules (30–36).
The incorporation of modified oligonucleotides, such as
locked nucleic acid (LNA) (26) or 2′-O-methyl (2OMe)
(37,38), into DNA oligos significantly increase the speci-
ficity and binding affinity of oligonucleotide probes toRNA
targets. The ISH methods, based on hapten-labeled LNA
oligos have been found to be highly advantageous in the de-
tection of miRNA in experimental and clinical tissue sam-
ples (39,40), whereas only a few attempts have been reported
for detection of mRNAs (41) and lncRNAs (42,43). The
DNA-LNA chimeric probes comprise typically 18–22 nt,
and can be single or double labeled with haptens, like digox-
igenin or carboxyfluorescein (FAM). Subsequent visualiza-
tion of the probe is performed with enzyme-conjugated an-
tibodies and chromogenic or fluorogenic substrates. The use
of a single oligo probe, optimally designed and with mini-
mum cross-binding to other RNAs, reduces the risk of off-
target probe hybridization and the use of LNA probes, in-
stead of pure DNA probes, increases the specificity of the
hybridization (26,44–47).
A third recently established ISH method is based on
bDNA technology. Here, two antisense DNA oligonu-
cleotides, comprising linker sequences and called double-Z
probes, are designed to bind adjacent sequences as pairs on
the target sequence. Dependent on the length of the RNA
target, up to 20 probe pairs may be designed into a sin-
gle bDNA probe set (27–29). The linker sequences of the
primary paired probes form a template for a second DNA
oligo that can bind only if the two paired probes have hy-
bridized in tandem on the same RNAmolecule. This probe
design provides a high level of specificity. The second de-
tecting oligo forms yet another template for additional de-
tection oligos, which together forms branches of DNA. The
last step in the procedure is the addition of DNA oligos that
can be either fluorophore-labeled or enzyme-conjugated,
eventually resulting in 8000- to 96 000-fold signal amplifi-
cation (27–29,48).
In this study, we have evaluated the performance of dif-
ferent fluorescence based ISH methods for the detection of
two different lncRNAs; the highly abundant metastasis as-
sociated in lung adenocarcinoma transcript 1 (MALAT1)
target and the less abundant CYTOR (previously called
long intergenic non-coding RNA 152 or linc00152). For the
comparison of fluorescence, we have used fluorophores with
similar spectral characteristics including probes labeled di-
rectly with Quasar-570 and Cy3 and the use of tyramide
signal amplification (TSA) systems with Cy3-labeled TSA
substrates for peroxidase. The TSA technology has in it-
self strongly contributed to the increase of sensitivity of ISH
methods (49,50).
In this study we have compared four different ISH meth-
ods: the multiple DNA probe detection approach using flu-
orophore labeled probe sets, a modified version of the mul-
tiple DNA probe detection approach, to the best of our
knowledge for the first time demonstrating the ability to
combine this with enzymatic amplification using the TSA
system, a bDNA probe detection format and a single oligo
probe detection system using LNA-modified oligos with en-
zymatic amplification.
MATERIALS AND METHODS
Cell culture and treatment
HeLa, NHDF dermal fibroblast and MCF7 breast adeno-
carcinoma cell lines were purchased fromATCC. Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS), 0.2 mM Ultra-
glutamine and 1% Penicillin/Streptomycin. T47D breast
cancer cells were a kind gift fromDrAgla Fridriksdo´ttir, In-
stitute for Cellular and Molecular Medicine, University of
Copenhagen, and were grown in RPMI-1640 supplemented
with 10%FBS, 0.25%Glucose, 2 mMofUltraglutamine, 10
g/ml of insulin and 0.2% Penicillin/Streptomycin. A549
lung adenocarcinoma cells and the different MALAT1
clones (51,52) were grown in DMEM containing 10% FBS,
0.2 mM Ultraglutamine and 1% Penicillin/Streptomycin.
All cell lines were maintained at 37◦C with 5% CO2. For
ISH experiments, cells were plated on Nunc™ Lab-Tek™ II
Chamber Slide system. Cells were fixed overnight in 10%
neutral-buffered formalin and subsequently washed and
stored in PBS. Before in situ hybridization analyses, cells
were permeabilized by incubation with 70% ethanol for 1h
at 4◦C.
In situ hybridization
Custom Stellaris® ISH probes were designed against
human MALAT1, human CYTOR using the Stellaris
RNA ISH Probe Designer (Biosearch Technologies, Inc.,
Petaluma, CA, USA) at http://www.biosearchtech.com/
stellarisdesigner (Stellaris Probe Designer version 4.2). A
probe set against mouse TNF was used as negative con-
trol. This probe was chosen due to its low homology (74%)
with the human TNF, and expected low expression of
TNF mRNA in the cultured human cells. The sequences
of probes are provided as supplementary information. Cells
were hybridized with Stellaris RNA ISH probes against
MALAT1, CYTOR or mTNF labeled either with ei-
ther Quasar 570 or 6-FAM, following the manufacturer’s
instructions available online at http://www.biosearchtech.
com/ with minor modifications. In brief, cells were incu-
bated with Quasar 570-labeled probes at 25 nM or FAM-
labeled probes at 2.5 nM in hybridization buffer (10% for-
mamide, 2× SSC) and hybridized overnight at 42◦C. Cells
were washed in hybridization buffer for 2 × 30 min at 42◦C
and briefly in 0.1× SSC. Cells hybridized with fluorescein-
labeled probes were first incubated in 3% hydrogen per-
oxide to block potential endogenous peroxidase, and then
the probes were detected with peroxidase-conjugated anti-
fluorescein-Ab (Roche applied Sciences, Mannheim, Ger-
many) diluted 1:400 followed by addition of Cy3-labeled
TSA substrate for 10 minutes (Perkin Elmer, Waltham,
MA, USA). All cells were mounted with ProLong® Gold
Antifade Mountant containing DAPI nuclear stain (Ther-
moFisher Scientific).
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In situ hybridization using double-FAM labeled LNA
probes (Exiqon, Vedbaek, Denmark) was performed as
described previously (53). The fixed and permeabilized
cells were pre-hybridized in hybridization buffer (53)
and then hybridized at 55◦C for 1 h with LNA probes
for MALAT1: 5′-ACATTGCCTACCACTCTAAGA-
3′ (Predicted RNA Tm = 84◦C) and CYTOR: 5′-
ATTCGATCAAGTGTGTCATAGA-3′ (Predicted RNA
Tm = 82◦C) and 5′-ATGTACACACGACTAAGAAGGA-
3′ (Predicted RNA Tm = 80◦C), and with a scramble
probe 5′-TGTAACACGTCTATACGCCCA-3′ (Predicted
RNA Tm = 87◦C) as negative control, all at 25 nM. The
FAM-labeled probes were detected as described above for
the FAM-labeled Stellaris probes.
Branched-DNA probe in situ hybridization was per-
formed using the ViewRNA® ISH Cell Assay Kit
(Affymetrix, Santa Clara, CA, USA), essentially according
to the manufacturer’s instructions. After pre-treatment, the
Type 1 bDNA probes against MALAT1 and CYTOR and
the negative control probe against bacterial dihydrodipi-
colinate reductase (dapB) mRNA (all at 10 nM) were hy-
bridized for 3 h at 40◦C. The bDNA probes were detected
using Alexa® Fluor 546 dyes, according to the manufac-
turer’s instructions. Cells weremountedwith ProLongGold
Antifade Mountant with DAPI (ThermoFisher Scientific).
Detailed information regarding the splice variant of each
target and the location and number of probes used in each
assay is provided in Table 1. Additionally, a file contain-
ing all the experimental information, according to theMIS-
FISHIE guidelines (54) is provided as SupplementaryData.
Imaging and image analysis
Images were acquired using a Zeiss Axio Imager Z1 epi-
fluorescence microscope equipped with an AxioCamMRm
CCD camera and a Plan-APOCHROMAT 63x/1.4 objec-
tive (Zeiss, Oberkochen, Germany). For imaging of the CY-
TOR ISH signals using the ViewRNA probe technology, an
optical sectioning system (ApoTome, Zeiss) was used to ac-
quire 11 z-stack images at 0.24 m intervals. The 11 z-stack
images were subsequently displayed using the maximum in-
tensity projection mode of the AxioVision40 version 4.8.2.0
image processing software (Zeiss) to create a single image
representing signals from all 11 z-stacks. Within the same
experiment, imageswere acquired at the same exposure con-
ditions.
The ImageJ software (55) was used to both obtain mean
pixel intensities for MALAT1 ISH signals and to count
numbers of the CYTOR ISH focal spots as follows. For
MALAT1 quantification, regions of interest were defined
by encircling the nuclei and the cytoplasm of individual
cells followed by a measurement of the fluorescence mean
pixel intensity of both nuclei and cytoplasm corrected for
the slide noise (signal outside the cells). Similarly, the fluo-
rescence signal of the negative control probes was measured
in the nuclei and cytoplasm of individual cells. For quantifi-
cation of the CYTOR ISH signal in nuclear and cytoplas-
mic regions, all images were identically processed by thresh-
olding, and the number of spots and foci was counted. For
both MALAT1 and CYTOR, quantification results were
obtained from at least six different images from a minimum
of three independent experiments, with more than 70 cells
measured per experimental condition.
siRNA transfection
For silencing of CYTOR the following
siRNA oligonucleotide was synthesized: 5′-
GGAAUGCAGCUGAAAGAUU-3′. MISSION®
siRNA Universal Negative Control (Sigma-Aldrich) was
used as a negative control. The siRNA’s were transfected at
a final concentration of 30 nM by reverse transfection using
RNAiMAX (Invitrogen) according to the manufacturer’s
instructions.
Total RNA isolation and RT-PCR
Total RNA from all the different cell lines, except for
MCF-7, was extracted using the RNeasy mini kit (Qiagen,
Hilden, Germany) according to manufacturer’s instruc-
tions. FromMCF-7 cells, total RNAwas isolated using Tri-
zol reagent (Invitrogen) and treated with TURBO DNase
(Ambion, Lifetechnologies). RNA reverse transcription
was performed using the reverse transcriptase from the Taq-
Man miRNA reverse transcription kit (Applied Biosystem,
Vilnius, Lithuania) with random primers (Thermo Fisher
Scientific, Waltham, MA, USA). For MALAT-1, quantita-
tive polymerase chain reactions (qPCRs) were performed
using Ampliqon RealQ Plus 2× Master Mix Green (Am-
pliqon A/S, Odense, Denmark), according to manufac-
turer’s instructions using a StepOnePlus™ Real-Time PCR
System instrument (Applied Biosystems). Previously pub-
lished primers forMALAT-1 (51) were used, and the house-
keeping gene GAPDH was used for normalization.
ForCYTOR, qPCRswere performed using SYBRGreen
PCR Fast PCR Master Mix 2× (Applied Biosystems) us-
ing a StepOnePlus Real-Time PCR System instrument
(Applied Biosystems) using the following two primers:
CYTOR-F: 5′-TCTTCACAGCACAGTTCCTGG-3′ and
CYTOR-R: 5′-AGGTAGAGGTGCTGGAGGG-3′. The
housekeeping genes GAPDH and HPRT1 were used for
normalization of qRT-PCR data. All the qPCR experi-
ments were conducted according to the MIQE guidelines
(56).
RESULTS
For detection of MALAT1 and CYTOR, we obtained
commercially available multiple singly-labeled probes
(Stellaris®), which were either Quasar 570-labeled for
direct detection or FAM-labeled for subsequent enzyme-
enhanced TSA detection. To test the bDNA probe
technology we used commercially available custom-made
ViewRNA® probe, and for single probe detection, we
designed double-FAM-labeled LNA probes. The coverage
of the three probe systems of the MALAT1 sequence, as
well as the principle of probe detection is illustrated in
Figure 1.
Comparison of ISH methods for detection of MALAT1
MALAT1 is expressed in a vast range of normal tissues (57)
and increased expression levels are found in most human
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Table 1. Detailed information about the lncRNA-variants studied and the types and number of probes used to detect both MALAT1 and CYTOR
Stellaris ViewRNA LNA + TSA Stellaris + TSA
Size of
transcript
































Figure 1. Schematic representation of ISH technologies used in this study. (A) Multiple DNA probe (Stellaris) technology without enzymatic signal
amplification (24,25), (B) bDNA (ViewRNA) technology (27), (C) LNA probe technology with enzymatic amplification (26) and (D) multiple DNA probe
(Stellaris) technology with enzymatic signal amplification.
cancers (reviewed in 58). MALAT1 is a highly abundant
transcript derived from multiple promoters and three dif-
ferent variants have been described (51). MALAT1 specifi-
cally localizes to nuclear speckles, where it is believed to in-
fluence transcription and RNA splicing (59,60). The abun-
dant expression and particular nuclear localization make
MALAT1 an ideal lncRNA for development and evalua-
tion of ISH methods. Prior to comparing the performance
of the individual ISH-methods cell culture conditions for
HeLa, NHDF and T47D cell lines were established and a
common fixation procedure, and individual optimization of
the four ISHmethods concerning probe concentrations and
hybridization conditions was performed.
Figure 2 shows representative images of the MALAT1
ISH results in the different cell lines using optimized hy-
bridization conditions. We generally observed a highly spe-
cific nucleus-associated signal in all cell lines; however, with
a high level of heterogeneity between individual cells. The
multiple probe direct detectionmethod (Stellaris) gave a dis-
tinct nuclear signal in NHDF and T47D cells and a weaker
signal in HeLa cells. The bDNA (ViewRNA) probe resulted
in nuclear staining in HeLa and T47D cells, and a weak sig-
nal in the NHDF cells. The LNA probe gave an intense nu-
clear signal in all three cell lines, and similarly, the enzyme-
enhanced Stellaris probe also detected MALAT1 in the nu-
clear structures in all three cell lines. This signal was con-
sistent with its known localization in the nuclear speckles
(59,60). None of the negative control probes used in the
four respective methods resulted in a nuclear staining pat-
tern similar to that of the MALAT1 probes (Figure 2).
Using digital images acquired at identical and non-
saturating exposure times, we quantitatively evaluated and
compared the performance of each of the ISH methods by
image analysis. Figure 3 shows the distribution of the mean
pixel intensities in the nucleus (nuc) and the cytoplasm (cyt),
respectively, of individual cells recorded from images across
the different cell lines and the different ISH methods, and
the associated quantitative parameters for eachmethod and
cell line is summarized in Table 2. In all cases, a significant
increase was measured in nucleus-associated MALAT1 sig-
nal compared to signal in the cytoplasm. For comparison,
a similar analysis was applied to mean pixel intensities ob-
tained for the negative control probes for each of the ISH-
methods (Supplementary Figure S1 and Table S1), and no
difference in the signal intensities between nucleus and cy-
toplasmic signal was found. The T47D cell line in three of
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Figure 2. Detection of MALAT1 in HeLa, NHDF and T47D cells. Detection of MALAT1 (red stain) in cells hybridized with a Quasar 570-labeled
Stellaris probe (Stellaris), a bDNA probe (ViewRNA®), a FAM-labeled LNA oligo-probe and a FAM-labeled Stellaris probe with subsequent peroxidase
mediated detection using Cy3 TSA (LNA+TSA and Stellaris+TSA, respectively). Cells were counter-stained with DAPI (blue stain). Images were acquired
at the same exposure conditions. Scale bar: 10 m.
the four ISH methods expressed the highest average signal
intensity in the nucleus (Table 2); however, in addition, the
T47D cells also showed the highest cytoplasmic signal cor-
responding to high background using all methods.
The two probe technologies without enzymatic amplifi-
cation, Stellaris and ViewRNA, resulted in 4- to 20-fold
lower ISH signal intensities than the probe technologies re-
lying on enzymatic amplification. However, since the back-
ground signal, defined as the cytoplasmic signal was equally
reduced, the signal-to-background ratio (i.e. nuc/cyt ra-
tio) was only marginally affected for the two methods. The
HeLa cells showed the highest variation in the nuc/cyt ratio
among the different methods, with the ViewRNA resulting
in a ratio of 7.6, and Stellaris in a ratio of 1.89. For compari-
son, theNHDF cells showed nuc/cyt ratios between 2.3 and
3.9. For the T47D cells, the nuc/cyt ratios across the meth-
ods were almost identical (2.5–2.7).
The ‘nuc-cyt’ values provided information about the dy-
namic intensity range of the ISH signal for comparison of
the different methods (Table 2), and were obtained by sub-
tracting the average signal intensity in the cytoplasm from
the average signal intensity of the nuclei. The Stellaris+TSA
method showed the highest dynamic range in all cell lines. In
the NHDF and T47D cells, the ViewRNA method showed
the lowest dynamic range of all methods. By adding the en-
zymatic TSA amplification to the Stellaris probe technol-
ogy, the dynamic range was increased 10- to 20-fold.
Quantitative real-time RT-qPCR analyses showed that
the T47D cells expressed 20-fold more MALAT1 than the
HeLa and NHDF cells, in which similar levels were mea-
sured (Supplementary Figure S2). A simple correlation
analysis of the qPCR and the mean intensities of the ISH
signal showed that theLNA-based ISHmethod had the best
correlation to the qPCR-based expression levels (data not
shown).
Specificity analyses of the MALAT1 ISH methods using
MALAT1 KO cells
To assess the specificity of the MALAT1 ISH methods,
we used a loss-of-function cellular model for MALAT1,
in which MALAT1 had been stably silenced using Zinc
Finger Nucleases (51,52). ISH analysis was performed us-
ing the four different detection methods in three different
MALAT1 wild-type clones (MALAT1 WT) and in three
knock-out clones (MALAT1 KO). All four ISH methods
stained MALAT1 in the nucleus consistent with a localiza-
tion in nuclear speckles and showed reduced signal in the
MALAT1 KO cell lines (Figure 4A and B; Supplementary
Figure S3). Calculating the ratio between the nuclear signals
obtained in MALAT1 WT cells and in MALAT1 KO cells
revealed that bDNA probe-based ISHmethod provided the
best specificity (Figure 4C).
Comparison of ISH methods for detection of CYTOR
CYTOR/linc00152 has been described in several cancers in-
cluding gastric cancer (61) and hepatocellular carcinoma
(62) and functional studies showed the involvement of
CYTOR in cell cycle regulation, apoptosis, epithelial-to-
mesenchymal transition and cell migration and invasion
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Figure 3. Comparative quantification of MALAT1 in HeLa, NHDF and T47D cells using four different ISH methods. Quantification of signal intensity
in individual cells is depicted as a vertical scatter plot. Each individual dot represents the signal of the mean pixel intensities in the nucleus (nuc) and the
cytoplasm (cyt), respectively, of individual cells recorded from images acquired at identical exposure times across the different cell lines and the different
ISH methods. The statistical differences of the MALAT1 signal in the nuclei and the cytoplasm were determined using a paired t-test.
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Table 2. Quantification of the Malat-1 ISH-signal in three different cell lines using four different probe technologies
HeLa NHDF T47D
Stellaris MALAT1 nuc 39 ± 2 N = 129 50 ± 2 N = 114 93 ± 23 N = 211
MALAT1 cyt 20 ± 1 N = 129 22 ± 2 N = 114 34 ± 1 N = 211
nuc-cyt 19 28 59
nuc/cyt ratio 1.9 2.3 2.7
ViewRNA MALAT1 nuc 186 ± 12 N = 132 18 ± 2 N = 117 78 ± 5 N = 227
MALAT1 cyt 24 ± 4 N = 132 8 ± 1 N = 117 28 ± 2 N = 227
nuc-cyt 162 10 50
nuc/cyt ratio 7.6 2.3 2.8
LNA+TSA MALAT1 nuc 456 ± 19 N = 139 246 ± 10 N = 123 774 ± 27 N = 215
MALAT1 cyt 150 ± 7 N = 139 63 ± 3 N = 123 299 ± 9 N = 215
nuc-cyt 307 183 475
nuc/cyt ratio 3.1 3.9 2.6
Stellaris+TSA MALAT1 nuc 693 ± 40 N = 91 357 ± 23 N = 88 991 ± 34 N = 149
MALAT1 cyt 292 ± 22 N = 91 91 ± 6 N = 88 393 ± 12 N = 149
nuc-cyt 401 266 598
nuc/cyt ratio 2.4 3.9 2.5
The mean signal intensity± the standard error of mean is given based on the quantification of individual cells (N). In each cell, the mean pixel intensity has
been determined in the nucleus (nuc) and the cytoplasm (cyt), respectively. The nuc-cyt value has been calculated by subtracting the signal of the cytoplasm
from the signal of nucleus. In addition, the ratio of the signal in the nucleus and the cytoplasm (nuc/cyt ratio) has been calculated.
(63). There are five different annotated transcript variants
of CYTOR, and in this study we have focused on variant
three which is the most abundant in MCF7 cells (unpub-
lished results). Initially, we assessed the expression level of
CYTOR and compared it with the expression level of the
highly abundant MALAT1 in the three cell lines by real-
time RT-PCR (Supplementary Figure S2). CYTOR is ex-
pressed between 100- and 350-fold lower than MALAT1
in HeLa and NHDF cells and more than 2000 fold lower
than MALAT1 in T47D cells. The NHDF cells expressed
the highest levels, and the HeLa cells the lowest.
The four different ISH methods were then employed for
CYTOR detection. The Stellaris direct probe approach did
not give any detectable signal above background (Supple-
mentary Figure S4); while the other three methods to a
varying degree gave signal in all three cell lines (Figure 5).
No significant signal was observed in cells hybridized with
the negative control probes.
The ISH signals observed with probes against CYTOR,
different from the nuclei-associated MALAT1 signals, ap-
peared as small single spots or foci both in the nuclei and the
cytoplasm, and we found that the image analysis approach
used for assessment ofMALAT1 was not useful for a quan-
titative assessment of CYTOR ISH performance. Instead,
the numbers of CYTOR foci present in the nucleus and in
the cytoplasm in individual cells were counted using image
analysis. The results of these analyses are shown in Figure
6A, where the average number of foci per cell in all three cell
lines are depicted using ViewRNA, the LNA+TSA and the
Stellaris+TSA probes for CYTOR and the respective neg-
ative control probes. With the ViewRNA probes, NHDF
cells presented an average of 50 foci per cell. The HeLa
cells in average had 40 foci and the T47D cells <5 foci
per cell (Figure 6A). In the NHDF cells, most of the pos-
itive foci were located in the cytoplasm, whereas in the
HeLa cells, CYTOR ISH signals were equally distributed
in the nucleus and the cytoplasm (Figure 5). Interestingly,
the bDNAprobe technology (ViewRNA) presented the best
signal-to-background ratios in all three cell lines (Figure
6B), primarily because the background signal was almost
absent. With the TSA-enhanced ISH methods, a high level
of background was observed, which significantly reduced
the signal-to-background ratio for these methods.
Specificity analyses of the CYTOR ISH method
Focusing on using the ViewRNA probe technology, we as-
sessed the specificity of the CYTOR ISH signal in MCF7
cells exposed to siRNA silencing CYTOR. In the MCF7
cells, a 15-fold reduction of CYTOR was determined by
RT-qPCR after siRNA silencing (Figure 7A). In theMCF7
cells, we found similar ISH signal foci representing CYTOR
as in the reference cell lines (Figure 7B), and therefore quan-
tified the ISH signals using the same image analysis pro-
cedure as above. The quantification showed that CYTOR
was almost 2-fold more expressed in the cytoplasm than in
the nucleus (Figure 7C), and that a significant reduction of
the total number of CYTOR ISH foci was measured in cells
transfected with CYTOR siRNAs compared to cells trans-
fected with a scramble siRNA (Figure 7C). Counting the
number of foci in the nuclei and in the cytoplasm separately,
we found a significant reduction of ISH signal foci in the
cytoplasm after siRNA treatment, whereas the number in
the nuclei largely remained unchanged, suggesting that the
siRNA treatment was most efficient in the cytoplasm (Fig-
ure 7C).
DISCUSSION
In this study, we evaluated four ISH probe technologies,
a Quasar-570-conjugated multiple probe set (Stellaris), a
bDNA (ViewRNA) probe set and twomodified ISHprobes,
a hapten-labeled Stellaris probe set and an LNA-modified
probe both detected with TSA, to visualize and quantify
two lncRNAs, MALAT1 and CYTOR in cultured cells. All
four ISH methods were capable of detecting the character-
istic nuclear signal of MALAT1, and three of the meth-
ods detected the weaker expressed CYTOR transcript. The
two methods using TSA resulted in a much higher signal
intensity compared to both the bDNA probe technology
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Figure 4. Analysis of MALAT1 ISH methods in MALAT1 knock-out cell lines. (A) Images of the ISH signal (red stain) for MALAT1 in the A549 WT
and in the MALAT1 knock-out cell line A549#671 using Quasar 570-labeled and FAM-labeled Stellaris probes, bDNA (ViewRNA), and LNA probes
as indicated. Cells were counter-stained with DAPI (blue stain). Images were acquired at the same exposure conditions. Scale bar: 10 m. (B) Depiction
of the average nuclear ISH signal obtained with the different ISH methods in three A549 wild-type clones (WT, #10, #83) and three A549 MALAT1
knock-out cell lines (#671, #752, #772). The diagram shows the mean intensity of the nuclear MALAT1 signal measured against the mean intensity of
the cytoplasmic ISH signal in each individual cell. Data represents average ± SEM of two experiments (n ≥ 30 cells for each condition/experiment). (C)
Depiction of the ratio between the average nuclear signals obtained in A459 MALAT1WT cells and in the MALAT1 knock-out A549 cells using the four
different ISH-methods.
and the Quasar-570-conjugated probe set. Thus, the enzy-
matic signal enhancement through TSA-enabled visualiza-
tion of MALAT1 using a single LNA probe and using the
hapten-labeled Stellaris probe set. The lower level of CY-
TOR was best detected with the bDNA probe, suggesting
that probe strategy and signal amplification are key factors
in ISH analyses of lncRNAs.
We used MALAT1 as a model for evaluation of the dif-
ferent ISH methods because MALAT1’s characteristic lo-
calization in nuclear speckles provided an immediate assess-
ment of the probes’ specificity. All four established methods
resulted in the typical MALAT1 ISH signal. In MALAT1
knock-out cells, generated by MALAT1 silencing (51), the
ISH signal was significantly reduced for all four ISH meth-
ods. The strongest effect of the MALAT1 knock-out was
observed with the bDNA and LNA probes, whereas the
Stellaris Quasar-570-conjugated probe set and the Stellaris
probe set with TSA showed the smallest reduction in sig-
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Figure 5. Detection of CYTOR in HeLa, NHDF and T47D cells. Detection of CYTOR (red stain) in cells hybridized a bDNA probe (ViewRNA), a
FAM-labeled LNA oligo-probe and a FAM-labeled Stellaris probe with subsequent peroxidase-mediated detection using Cy3 TSA (LNA + TSA and
Stellaris + TSA, respectively). Cells were counter-stained with DAPI (blue stain). Images were acquired at the same exposure conditions. Scale bar: 10 m.
nal. These observations can be explained by the inherent
specificity of the probes and the risk of exhibiting off-target
binding. The bDNA method has an in-built restriction in
which signal can only be generated if two detecting oligos
bind to adjacent sequences on the RNA target, while the
LNA probe is designed to have minimum off-targets using
Exiqon’s probe design tool. Also the Stellaris probe sets are
designed to exhibit minimum off-target effects, but the risk
that one or more out of up to 48 probes show off-target
binding is higher. Cabili et al. reported issues with off-target
binding in a subset of the Stellaris probes analyzed (64). The
requirement for probe specificity is even higher for RNAs
expressed at lower level as the CYTOR. We found that CY-
TOR was best detected using the ViewRNA probe set and
showed localization in both cytoplasm and nuclei. The ISH
signal obtained in the cytoplasmic compartment was signif-
icantly reduced in siRNA-treated cells, whereas the nuclear
signal appeared unaffected. Since the nuclear CYTOR ISH
signal was well over background, our observation may be
related to the efficiency of siRNA knock-down being less
efficient in the nuclear compartment. Indeed, it has been
reported that in general siRNA-mediated silencing is more
efficient for lncRNAs residing in the cytoplasm (65). ByRT-
qPCR the CYTOR expression level was reduced 15-fold af-
ter the siRNA treatment and the siRNA treatment is there-
fore not a full depletion of the transcript. The observations
taken together suggest that specificity analyses of ISHmeth-
ods applied to cultured cells should include both RT-qPCR
to establish the expression level and knock-out or know-
down cells to evaluate off-target binding. It should be added
that Cabili et al. (64) used a two-probe system with two
differently labeled non-overlapping Stellaris probes, which
represented an elegant approach to confirm the specificity
of Stellaris probes.
In order to compare the sensitivity of the methods we
used image analysis, where the total nuclear MALAT1
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Figure 6. Comparative quantification of CYTOR detection in HeLa, NHDF and T47D cells using three different ISH methods. (A) The average number
of ISH signal foci per cell were obtained with the CYTOR probes (ViewRNA, LNA+ TSA and Stellaris + TSA) and the respective negative control probes
(bacterial dapB ViewRNA probe, scramble LNA probe and murine TNF Stellaris probe). (B) The average signal-to-noise ratio of the three different ISH
methods in the three cell lines are depicted by dividing the CYTOR signal with the signal of the respective negative control probes.
ISH signal was measured relative to that in the cytoplasm
(nuc/cyt ratios). The image analysis approach identified
variation in the mean pixel intensity of the MALAT1 ISH
signal, which we considered as representative expression es-
timates of the different cell lines and allowed a promiscu-
ous comparison of the ISHmethods. The image analysis for
all four ISH methods measured highest expression levels in
the T47D cells, which was in agreement with our RT-qPCR
findings. We observed a discrete MALAT1 ISH signal in
HeLa cells using the Quasar-570 conjugated oligo probes
using a 63× objective. This finding appears surprising since
Cabili et al. found abundantMALAT1 signal in their HeLa
cells (64), but may be explained by the use of Alexa-594 la-
beled Stellaris® probes and/or their use of a 100× objec-
tive for evaluation of the expression. Attempts to increase
the sensitivity of the multiple probe set by adding antibody-
based probe detection followed by enzymatic signal amplifi-
cation (TSA) allowed better visualization of the ISH signal,
but also increased the background level, which disturbed
the overall sensitivity of the assay. Thus, the background
levels were also elevated and only a marginal improvement
of the signal-to-background ratio was seen. However, en-
zymatic signal amplification was very efficient in the detec-
tion of the LNA probe for MALAT1, for which the image
analysis-based expression estimates showed the best associ-
ation with the RT-qPCR data.
To obtain quantitative expression estimates for CYTOR
in the three cell lines, we applied a spot-based ISH signal
detection and counted the number of signal foci in both nu-
clei and cytoplasm. The detection of spots is limited by the
diffraction limit of themicroscope, which in this case is∼0.5
m using a 63× objective with a numerical aperture of 1.4
in the Cy3/Quasar570/Alexa Fluor 546-fluorescence chan-
nel. This approach is similar to the one employed by Cabili
et al. (64), who counted the number of ISH signal spots for a
variety of lncRNAs after hybridization with Stellaris probes
on cultured cells. In this study, we counted ISH signal foci
for CYTOR after hybridization with the bDNA probe both
within the nuclei and in the cytoplasm, and found ISH sig-
nal in both regions. The foci-based CYTOR expression es-
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Figure 7. Evaluation of CYTOR ISH in CYTOR knock-down cell lines. (A) RT-qPCR measurements of CYTOR expression in MCF7 cells transfected
with a siRNA with a scramble sequence or against CYTOR. GAPDHmRNA levels were used to normalize gene expression. (B) CYTOR ISH signal (red
stain) and dapB ISH signal (negative control) in MCF7 cells transfected with scramble- or CYTOR-specific siRNA. Cells were counter-stained with DAPI
(blue stain), scale bar: 10 m. (C) Quantification of the CYTOR ISH signal (number of positive spots or foci per cell) in the nucleus and in the cytoplasm
of the siRNA treated cells. Data represents average ± SEM of at least three experiments (n ≥ 30 cells for each condition/experiment).
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timates identified highest total levels in the NHDF cells
among the three cell lines studied, which was in agreement
with our RT-qPCR findings. The low level of ISH signal ob-
tained by the other ISH methods is likely associated with
the low expression level of CYTOR. The RT-qPCR data
indicated a more than 100-fold lower expression level than
MALAT1. Factors such as the secondary and tertiary struc-
ture of the RNA and the interaction with RNA-binding
proteins can render the target sites inaccessible to the probes
(66), which may help to explain the poor signal since the
enzyme-based signal amplification methods also resulted in
weak CYTOR ISH signal.
The Quasar-570-conjugated Stellaris probe set and the
ViewRNA probe set have been reported to allow single
molecule detection (24–25,27–29), meaning that each spot
of a certain size represent a single RNA molecule. A con-
glomerate of spots may fuse into single foci. In this study,
all nuclear MALAT1-positive spots are likely to represent
more than single molecules, whereas the single spots iden-
tified in the CYTOR ISH are more likely to represent sin-
gle molecules. The TSA-based ISH methods for detection
of MALAT1 resulted in larger spots and are considered
unlikely to represent distinct single molecules. The use of
TSA-based systems to detect long transcripts is not widely
used in cultured cells, despite some early references (67,68),
but it has been used to detect miRNAs in several studies
(69–71). TSA is a peroxidase-based amplification system
that in immunohistochemistry has been reported to am-
plify signal 100-fold. The amplification method may not
provide staining at single molecule resolution, because the
reactive product from the enzymatic reaction diffuses and
bind tyrosine residues of neighbouring proteins. Obviously,
unspecific bound probe will also cause amplification and
increased background signals. The control of hybridization
specificity is therefore important for this staining method.
The subcellular localization of lncRNAs has been found
to be dramatically different from that of mRNAs (30).
Whereas most mRNAs are transferred to the cytoplasm,
most lncRNAs are located in the nuclei. In the nuclei, the
lncRNAs are associated with chromatin, where the tran-
scripts bind chromatin-modifying protein complexes and
act in regulating gene expression (30). A vast majority of the
lncRNAs studied by Cabili et al. (64) localized to the nuclei,
includingMALAT1, and around 40% the studied lncRNAs
were also seen in the cytoplasm. For most of the lncRNAs,
the localization of lncRNAs was noted to be dependent on
the cell cycle, thus, Cabili et al. reported that mitotic cells
lost the nuclear signal (64). As mentioned above, we found
CYTOR ISH signal both in the cytoplasm and in the nuclei
in all the four untreated cell lines. Compared to MALAT1,
CYTOR is a relatively poorly described lncRNA. In the few
studies published, the localization of theCYTOR transcript
has been reported in the cytoplasm of gastric cancer cell
lines (72), and in the nuclei of a hepatocellular carcinoma
(73) and lung adenocarcinoma cell line (74), suggesting that
CYTORmay have different functions in different cell types.
Compared to each other the four ISHmethods presented
both benefits and limitations, which can be evaluated in re-
lation to ease of handling, time, signal properties, sensitivity
and specificity of the assays. At one end is themultiple probe
technology (Stellaris) involving a simple and fast ‘one-step
detection method’, which, however, also shows limitations
in specificity, with risk of off-target binding, and sensitivity
since it does not include signal amplification except for the
multiplication of fluorophore labeled probes (up to 48 per
target). Hence, the Stellaris method would be preferred for
long and abundant targets, where highly specific probe sets
can be designed. In the other end, the bDNA ISH method
uses a more laborious five-step detection method, which,
however, can be automated. The bDNAmethod, has a high
level of specificity because of the double-Z probe design,
and has in this study shown a high level of sensitivity inher-
ent to the five-step signal amplification procedure that in the
end in theory can give a 8000 times higher number of labels
per target compared to a single fluorophore-labeled probe.
This very localized signal amplification is in fact claimed to
allow for detection of singlemolecules, and the spotty signal
can be counted as such. Supported by the results presented
in this study, the bDNAmethod is recommended especially
for low abundant lncRNA targets. The two remainingmeth-
ods that were tested both rely on enzymatic amplification
using TSA-system. The LNA+TSA-based method is, with
its three-step procedure less complex than the bDNA-ISH
method, and the use of LNA-containing probes has proven
to increase specificity compared to using DNA-probes. The
use of the TSA-system provides higher signal intensities
compared to both Stellaris and bDNA-ISH methods; how-
ever, with an associated higher background signal as well.
The LNA+TSA method may be chosen for both low and
high abundant lncRNAs, but a panel of probe designs is re-
quired to find the best probe. The Stellaris+TSA method
is an elaboration of the conventional Stellaris-method in-
troducing an enzymatic amplification step using the TSA-
system similar to the LNA+TSA, and, hence, has more or
less the same complexity in handling. Similar to the direct
Stellaris approach, this procedure also presents potential
limitations regarding specificity due to off-target binding.
The use of the TSA-system in association with the Stellaris-
probes gives much higher signal intensities compared to the
direct approach, but like with the LNA+TSA method also
with an accompanied increase in background signal. In this
study, we have shown that the modification of the Stellaris
direct ISH-method actually improved the performance of
the Stellaris probes to detect the less expressed CYTOR
target, which could not be detected by the direct method.
We recommend this method to be used in cases where gene-
targeted knock-out cells are available to confirm reliability
and specificity of the detection system.
In conclusion, we have reported a comparison of ISH
methods to detect lncRNAs in cultured cells, as exemplified
by MALAT1 and CYTOR. We evaluated assay specificity
by referring to control probes, knock-down cells and RT-
qPCR data, and evaluated assay sensitivity using different
image analysis approaches. For the two targets, MALAT1
and CYTOR, representing high and weakly expressed tran-
scripts, respectively, we found that all four ISH methods al-
lowed detection of MALAT1 and, except from the direct
Stellaris method also CYTOR. Our findings suggest that
knowledge about a transcript, in terms of expression level
and subcellular localization, is advantageous for selecting
the optimal ISH method for a given target.
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